Methylprednisolone Completed Phase 4 Trials for HLA Sensitization Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00908583Desensitization in Kidney Transplantation